Immunity and pathogens

The Immunity and Pathogen Research Division is positioned to address the growing complexity of global health challenges, especially at the crossroads between pandemics like COVID-19, climate change, and the emergence of new infectious diseases. Its role is to offer a holistic approach to exploring, facing, and preventing threats to public health, which range from immune response to the intricate interactions between pathogens and the environment. The division’s mission is to understand the mechanisms of viral and bacterial diseases and those that more intensely affect vulnerable populations, like Chagas disease. To carry out this mission, it has medium and high containment biosafety laboratories (BSL-2 and BSL-3) for handling pathogens that are critical to public health, such as SARS-CoV-2 (Covid), the virus that causes yellow fever, and the Mayaro and Rocio viruses.

Bacteria

This group explores the development of antibiotics to combat multi-drug-resistant bacteria, a critical concern worldwide for public health

DISCOVER

Chagas

This group studies neglected parasitic diseases such as Chagas, which are associated with poverty and precarious health conditions

DISCOVER

Study on new targets for treating Chagas disease wins prize

Postdoctoral researcher at CNPEM receives Zigman Brener Award for work introducing a new molecule with potential to become an alternative for treating infections by the Trypanosoma cruzi parasite Caio Cesar de Lima Silva, a postdoctoral fellow linked to the FINEP project “Development of new molecules to combat Chagas disease exploring non-conventional targets,” coordinated by Dr.…

DISCOVER

Immunity and pathogens